eMedicine Specialties > Neurology > Inflammatory and Demyelinating Diseases

Tolosa-Hunt Syndrome: Differential Diagnoses & Workup

Author: Danette C Taylor, DO, MS, Clinical Associate Professor, Department of Neurology, Michigan State University College of Osteopathic Medicine; Senior Staff Neurologist, Franklin Pointe Medical Center, Henry Ford Health Systems
Contributor Information and Disclosures

Updated: Mar 12, 2009

Differential Diagnoses

Anisocoria
Migraine Headache
Arteriovenous Malformations
Migraine Headache: Neuro-Ophthalmic Perspective
Benign Skull Tumors
Neurosarcoidosis
Cavernous Sinus Syndromes
Pituitary Tumors
Cerebral Aneurysms
Polyarteritis Nodosa
Cerebral Venous Thrombosis
Primary CNS Lymphoma
Craniopharyngioma
Primary Malignant Skull Tumors
Diabetic Neuropathy
Systemic Lupus Erythematosus
Epidural Hematoma
Tuberculous Meningitis
Extraocular Muscles, Actions
Varicella Zoster
Extraocular Muscles, Anatomy
Wegener Granulomatosis
Lyme Disease
Whipple Disease
Meningioma
Metastatic Disease to the Brain

Other Problems to Be Considered

Carotid-cavernous fistula
Cavernous angioma
Fungal infections
Lymphoma
Melanoma
Miller Fisher Syndrome
Orbital myositis
Orbital pseudotumor
Syphilis
Vasculitis
Giant cell arteritis

Workup

Laboratory Studies

  • The diagnosis of Tolosa-Hunt syndrome is usually one of exclusion.
  • Laboratory workup: CBC count, erythrocyte sedimentation rate (ESR), electrolytes with glucose, thyroid function tests, fluorescent treponemal antibody (FTA), antinuclear antibody (ANA), lupus erythematosus (LE) preparation, antineutrophil cytoplasmic antibody (ANCA), serum protein electrophoresis, Lyme titre, angiotensin-converting enzyme (ACE) level, and HIV titre are helpful in eliminating other processes. This level of evaluation is required to exclude other conditions, which can have significant morbidity associated.
  • Cerebrospinal fluid (CSF) studies: Cell count and differential, protein, glucose, fungal and/or bacterial cultures, Gram stain, cytology, and opening pressure of CSF are helpful in eliminating conditions mimicking Tolosa-Hunt syndrome; a mild (lymphocytic) pleocytosis within the spinal fluid may occur in patients with Tolosa-Hunt syndrome.
  • Anti-GQ1b antibodies may be helpful in distinguishing early, painless Tolosa-Hunt syndrome from Miller Fisher syndrome.

Imaging Studies

  • MRI3 of the brain and orbit with and without contrast, magnetic resonance (MR) angiography or digital subtraction angiography (DSA), and CT scan of the brain and orbit with and without contrast may all be useful. Inflammatory changes in the cavernous sinus, superior orbital fissure, and/or orbital apex are typically observed on high-resolution contrast-enhanced imaging. In the authors' experience, thin-slice high–magnetic field MRI of the cavernous sinus region, including coronal sections with and without contrast and fat-suppressed cuts of the orbital regions, is the modality of choice. These changes are not specific for Tolosa-Hunt syndrome and may also be present in neoplastic conditions of the cavernous sinus. Enlargement of the optic nerve or external ocular muscles has been described, emphasizing the continuum with idiopathic orbital inflammatory disorders.
  • Note that findings on all imaging studies may be normal in some cases of Tolosa-Hunt syndrome.
  • Narrowing of the internal carotid artery within the cavernous sinus may be identified on angiography. Note that these changes are not specific to Tolosa-Hunt syndrome.
  • MRI with 3-dimensional constructive interference in steady state (3D CISS) provides an enhanced picture within the cavernous sinus. This type of imaging may assist with future diagnoses of TSH, but it is not yet used routinely.4
MRI of a 40-year-old man with severe periorbital ...

MRI of a 40-year-old man with severe periorbital pain ocular sinister (OS; ie, left eye), complete oculomotor nerve palsy OS, and partial abducens nerve palsy OS (image 1 is axial; image 2 is coronal). Axial imaging without (left) and with (right) enhancement demonstrates nonspecific fullness involving the left cavernous sinus, consistent with Tolosa-Hunt syndrome within the context of the history. Treatment with steroids produced complete resolution of symptoms. Image courtesy of Eric Eggenberger, DO.

MRI of a 40-year-old man with severe periorbital ...

MRI of a 40-year-old man with severe periorbital pain ocular sinister (OS; ie, left eye), complete oculomotor nerve palsy OS, and partial abducens nerve palsy OS (image 1 is axial; image 2 is coronal). Axial imaging without (left) and with (right) enhancement demonstrates nonspecific fullness involving the left cavernous sinus, consistent with Tolosa-Hunt syndrome within the context of the history. Treatment with steroids produced complete resolution of symptoms. Image courtesy of Eric Eggenberger, DO.


Coronal T1-weighted MRI with (below) and without ...

Coronal T1-weighted MRI with (below) and without (above) enhancement demonstrates left cavernous sinus fullness consistent with Tolosa-Hunt syndrome (THS). The imaging features are nonspecific and must be placed into the context of the history, examination, and clinical course to avoid misdiagnosis of infiltrating, infectious, or neoplastic cavernous sinus processes. Image courtesy of Eric Eggenberger, DO.

Coronal T1-weighted MRI with (below) and without ...

Coronal T1-weighted MRI with (below) and without (above) enhancement demonstrates left cavernous sinus fullness consistent with Tolosa-Hunt syndrome (THS). The imaging features are nonspecific and must be placed into the context of the history, examination, and clinical course to avoid misdiagnosis of infiltrating, infectious, or neoplastic cavernous sinus processes. Image courtesy of Eric Eggenberger, DO.


Procedures

Biopsy of the lesion may be required to confirm the diagnosis. The technical difficulty of cavernous sinus region biopsies usually mitigates for a trial of steroids; nonetheless, biopsy may be needed to exclude neoplasm or if symptoms are progressing, atypical, or recurrent.

Histologic Findings

Biopsy reveals nonspecific granulomatous or nongranulomatous inflammation. This is histologically indistinguishable from the pathology of orbital pseudotumor, and these diseases may exist along a continuum.

More on Tolosa-Hunt Syndrome

Overview: Tolosa-Hunt Syndrome
Differential Diagnoses & Workup: Tolosa-Hunt Syndrome
Treatment & Medication: Tolosa-Hunt Syndrome
Follow-up: Tolosa-Hunt Syndrome
Multimedia: Tolosa-Hunt Syndrome
References

References

  1. Lachanas VA, Karatzias GT, Tsitiridis I, Panaras I, Sandris VG. Tolosa-Hunt syndrome misdiagnosed as sinusitis complication. J Laryngol Otol. Jan 2008;122(1):97-9. [Medline].

  2. Colnaghi S, Versino M, Marchioni E, Pichiecchio A, Bastianello S, Cosi V, et al. ICHD-II diagnostic criteria for Tolosa-Hunt syndrome in idiopathic inflammatory syndromes of the orbit and/or the cavernous sinus. Cephalalgia. Jun 2008;28(6):577-84. [Medline].

  3. Goto Y, Hosokawa S, Goto I, et al. Abnormality in the cavernous sinus in three patients with Tolosa-Hunt syndrome: MRI and CT findings. J Neurol Neurosurg Psychiatry. Mar 1990;53(3):231-4. [Medline].

  4. Yagi A, Sato N, Taketomi A, et al. Normal cranial nerves in the cavernous sinuses: contrast-enhanced three-dimensional constructive interference in the steady state MR imaging. AJNR Am J Neuroradiol. Apr 2005;26(4):946-50. [Medline].

  5. Cohn DF, Carasso R, Streifler M. Painful ophthalmoplegia: the Tolosa-Hunt syndrome. Eur Neurol. 1979;18(6):373-81. [Medline].

  6. Gimenez-Roldan S, Guillem A, Munoz L. [Long-term risk of relapses in Tolosa-Hunt syndrome]. Neurologia. Sep 2006;21(7):382-5. [Medline].

  7. Barontini F, Maurri S, Marrapodi E. Tolosa-Hunt syndrome versus recurrent cranial neuropathy. Report of two cases with a prolonged follow-up. J Neurol. Feb 1987;234(2):112-5. [Medline].

  8. Bruyn GW, Ferrari M, de Beer FC. Migraine, Tolosa-Hunt syndrome and pleocytosis. Correlation or coincidence?. Clin Neurol Neurosurg. 1984;86(1):33-41. [Medline].

  9. Hunt WE. Tolosa-Hunt syndrome: one cause of painful ophthalmoplegia. J Neurosurg. May 1976;44(5):544-9. [Medline].

  10. Johnston JL. Parasellar syndromes. Curr Neurol Neurosci Rep. Sep 2002;2(5):423-31. [Medline].

  11. Kline LB. The Tolosa-Hunt syndrome. Surv Ophthalmol. Sep-Oct 1982;27(2):79-95. [Medline].

  12. Kline LB, Hoyt WF. The Tolosa-Hunt syndrome. J Neurol Neurosurg Psychiatry. Nov 2001;71(5):577-82. [Medline].

  13. Kobor J, Voros E, Deak A. Magnetic resonance imaging in Tolosa-Hunt syndrome. Eur J Pediatr. Dec 2004;163(12):753-4. [Medline].

  14. Kwan ESK, Wolpert SM, Hedges TR III. Tolosa-Hunt revisited: Not necessarily a diagnosis of exclusion. Am J Radiol. 1989;71:932.

  15. La Mantia L, Erbetta A, Bussone G. Painful ophthalmoplegia: an unresolved clinical problem. Neurol Sci. May 2005;26 Suppl 2:s79-82. [Medline].

  16. Lo YL, Chan LL, Pan A, Ratnagopal P. Acute ophthalmoparesis in the anti-GQ1b antibody syndrome: electrophysiological evidence of neuromuscular transmission defect in the orbicularis oculi. J Neurol Neurosurg Psychiatry. Mar 2004;75(3):436-40. [Medline].

  17. Roca PD. Painful ophthalmoplegia: the Tolosa-Hunt syndrome. Ann Ophthalmol. Jun 1975;7(6):828-34. [Medline].

  18. Schutta HS. Diseases of the dura mater. In: Joynt R, Griggs R, eds. Clinical Neurology. Philadelphia, Pa: Lippincott, Williams & Wilkins; 1993:34-44.

  19. Smith JL, Taxdal DS. Painful ophthalmoplegia. The Tolosa-Hunt syndrome. Am J Ophthalmol. Jun 1966;61(6):1466-72. [Medline].

  20. Sondheimer FK, Knapp J. Angiographic findings in the Tolosa-Hunt syndrome: painful ophthalmoplegia. Radiology. Jan 1973;106(1):105-12. [Medline].

  21. Spector RH, Fiandaca MS. The "sinister" Tolosa-Hunt syndrome. Neurology. Feb 1986;36(2):198-203. [Medline].

  22. Troost BT. Miller NR, Newman NJ, eds. Walsh & Hoyt's Clinical Neuro-Ophthalmology. Philadelphia, Pa: Williams & Wilkins Company; 1998:1727-29.

  23. Vallat JM, Vallat M, Julien J, et al. Painful ophthalmoplegia (Tolosa-Hunt) accompanied by peripheral facial paralysis. Ann Neurol. Dec 1980;8(6):645. [Medline].

  24. Yousem DM, Atlas SW, Grossman RI, et al. MR imaging of Tolosa-Hunt syndrome. AJR Am J Roentgenol. Jan 1990;154(1):167-70. [Medline].

Further Reading

Keywords

Tolosa-Hunt syndrome, THS, painful ophthalmoplegia, idiopathic cavernous sinus inflammation, inflammation of the superior orbital fissure, painful ophthalmoparesis, inflammation of the cavernous sinus fissure

Contributor Information and Disclosures

Author

Danette C Taylor, DO, MS, Clinical Associate Professor, Department of Neurology, Michigan State University College of Osteopathic Medicine; Senior Staff Neurologist, Franklin Pointe Medical Center, Henry Ford Health Systems
Danette C Taylor, DO, MS is a member of the following medical societies: American Academy of Neurology, American Medical Association, and American Osteopathic Association
Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; Boeringher Ingelheim Honoraria Speaking and teaching; Teva  Honoraria Speaking and teaching

Medical Editor

Eric R Eggenberger, DO, MS, FAAN, Professor, Vice-Chairman, Department of Neurology and Ophthalmology, Colleges of Osteopathic Medicine and Human Medicine, Michigan State University; Director of Michigan State University Ocular Motility Laboratory; Director of National Multiple Sclerosis Society Clinic, Michigan State University
Eric R Eggenberger, DO, MS, FAAN is a member of the following medical societies: American Academy of Neurology, American Academy of Ophthalmology, American Osteopathic Association, and North American Neuro-Ophthalmology Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Florian P Thomas, MD, MA, PhD, Drmed, Director, Spinal Cord Injury Unit, St Louis Veterans Affairs Medical Center; Director, National MS Society Multiple Sclerosis Center; Professor, Department of Neurology and Psychiatry, Associate Professor, Institute for Molecular Virology, and Department of Molecular Microbiology and Immunology, St Louis University
Florian P Thomas, MD, MA, PhD, Drmed is a member of the following medical societies: American Academy of Neurology, American Paraplegia Society, and National Multiple Sclerosis Society
Disclosure: Nothing to disclose.

CME Editor

Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants
Nicholas Y Lorenzo, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Neurology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.